why choose us

First received: July 25, 2023

Clinical Trial: A Study of mRNA-1018 Pandemic Influenza Candidate Vaccines in Healthy Adults

Study Status: Completed

Recruit Status: RECRUITING

Condition: Influenza

Study Type: INTERVENTIONAL


Official Title: Phase 1/2, Randomized, Observer-Blind, Parallel, Dose-Ranging Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1018 Pandemic Influenza Candidate Vaccines in Healthy Adults

Brief Summary: The purpose of this Phase 1/2 study is to generate sufficient safety and immunogenicity data of mRNA-1018 pandemic influenza candidate vaccines in healthy adults ?18 years of age to enable the initiation of a large Phase 3 trial with one selected vaccine candidate.The study will be conducted in 2 Parts (Part A and Part B) that will enroll and run concurrently.Part A of the study will evaluate 4 vaccine candidates (H5N8, H7N9, H5 only, and H7 only).Part B of the study will evaluate a single vaccine candidate…

Read more